05/08/2015 02:27:26 Free Membership Login

Xenoport News (NASDAQ:XNPT)

DateTimeSource
Headline
07/27/201510:00AMBWXenoPort to Release Second Quarter Financial Results on August 5, 2015
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its second quarter financial results on August 5, 2015 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A... More...>>
06/25/20158:30AMBWXenoPort Announces Initiation by NIAAA of Clinical Trial of HORIZANT in Patients with Alcohol Use Disorder
XenoPort, Inc. (Nasdaq:XNPT) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced today that the NIAAA has initiated a clinical trial of HORIZANT® (gabapentin enacarbil) Extended-Release Tablets as a potential treatment for alcohol use disorder (AUD). “This multi-site, well-controlled clinical... More...>>
06/08/20158:30AMBWHORIZANT (gabapentin enacarbil) Included in New Expert Recommendations on Prevention and Treatment of RLS Augmentation
XenoPort, Inc. (Nasdaq:XNPT) reported today that new expert recommendations for the prevention and treatment of augmentation in patients suffering from restless legs syndrome (RLS) list gabapentin enacarbil as a first-line therapy with a lower risk of developing augmentation. In addition, gabapentin enacarbil is listed... More...>>
06/02/20158:30AMBWXenoPort to Present New Pooled Data Analyses on HORIZANT (gabapentin enacarbil) at the 2015 SLEEP Annual Meeting
XenoPort, Inc. (Nasdaq: XNPT) announced today that pooled data analyses for HORIZANT® (gabapentin enacarbil) Extended-Release Tablets, will be presented at the upcoming 29th Associated Professional Sleep Societies (APSS) annual SLEEP meeting in Seattle. The presentations include: Association Between Pain and Symptoms... More...>>
05/18/201510:00AMBWXenoPort to Present at the Jefferies 2015 Global Healthcare Conference
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Jefferies 2015 Global Healthcare Conference. The live presentation will occur at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) on Thursday, June 4, 2015. A replay of the presentation will also be... More...>>
05/07/20158:30AMBWXenoPort to Present New HORIZANT (gabapentin enacarbil) Data at the American Pain Society 34th Annual Scientific Meeting
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present data for HORIZANT® (gabapentin enacarbil) Extended-Release Tablets at the American Pain Society 34th Annual Scientific Meeting in Palm Springs, CA. HORIZANT is approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate-to-severe... More...>>
05/06/20154:05PMBWXenoPort Reports First Quarter Financial Results
XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the first quarter ended March 31, 2015. Revenues for the quarter were $7.1 million, compared to $3.4 million for the same period in 2014. Net loss for the first quarter was $20.4 million, compared to a net loss of $20.5 million for the same period... More...>>
05/01/20153:18PMARNZacks Lowers XenoPort to Hold (XNPT)
http://tickerreport.com/banking-finance/491451/zacks-lowers-xenoport-to-hold-xnpt/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/30/20152:29PMARNXenoPort Upgraded to "Buy" by Zacks (XNPT)
http://tickerreport.com/banking-finance/486917/xenoport-upgraded-to-buy-by-zacks-xnpt/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/28/20151:00PMBWXenoPort to Release First Quarter Financial Results on May 6, 2015
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its first quarter financial results on May 6, 2015 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A replay... More...>>
04/15/20158:30AMBWXenoPort to Present New Data Analyses for HORIZANT (gabapentin enacarbil) at the 67th Annual Meeting of the American Academy ...
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present pooled post-hoc analyses for gabapentin enacarbil, the active ingredient in HORIZANT® (gabapentin enacarbil) Extended-Release Tablets, at the upcoming 67th Annual Meeting of the American Academy of Neurology in Washington, DC. HORIZANT is approved by the... More...>>
02/23/201510:00AMBWXenoPort to Present at the Cowen and Company 35th Annual Health Care Conference
XenoPort, Inc. (NASDAQ: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Cowen and Company 35th Annual Health Care Conference. The live presentation will occur at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on Wednesday, March 4, 2015. A replay of the presentation... More...>>
02/19/20154:05PMBWXenoPort Reports Fourth Quarter and Year-End 2014 Financial Results
XenoPort, Inc. (Nasdaq:XNPT) announced today its financial results for the fourth quarter and year ended December 31, 2014. Revenues for the fourth quarter were $7.1 million compared to $2.9 million for the same period in 2013. Net loss for the fourth quarter was $17.7 million compared to a net loss of $19.1 million for... More...>>
02/18/20154:30PMBWXenoPort to Present at the RBC Capital Markets’ Global Healthcare Conference
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the RBC Capital Markets’ Global Healthcare Conference. The live presentation will occur at 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time) on Wednesday, February 25, 2015. A replay of the presentation... More...>>
02/05/201510:00AMBWXenoPort to Release Fourth Quarter and Year-End Financial Results on February 19, 2015
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its fourth quarter and year-end financial results on February 19, 2015 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business... More...>>
01/29/20159:00AMBWXenoPort Announces Pricing of $100 Million 2.50% Convertible Senior Notes due 2022
XenoPort, Inc. (NASDAQ: XNPT) announced today the pricing of $100 million aggregate principal amount of 2.50% Convertible Senior Notes due 2022 in a private placement to qualified institutional buyers pursuant to Rule 144A (the “offering”) under the Securities Act of 1933, as amended (the “Securities Act”). In... More...>>
01/28/20154:36PMBWXenoPort Announces Proposed Offering of $100 Million Convertible Senior Notes due 2022
XenoPort, Inc. (Nasdaq: XNPT) announced today that it intends to offer, subject to market and other conditions, $100 million aggregate principal amount of convertible senior notes due 2022 in a private placement to qualified institutional buyers pursuant to Rule 144A (the “offering”) under the Securities Act of 1933... More...>>
01/11/20151:00PMBWXenoPort Provides Highlights of HORIZANT Prescription Trends and Update on Development for Alcohol Use Disorder
XenoPort (NASDAQ:XNPT) today reported an update on prescription trends and further development of HORIZANT® (gabapentin enacarbil) Extended-Release Tablets, including feedback from the U.S. Food and Drug Administration (FDA) on development for treatment of alcohol use disorder (AUD). HORIZANT prescription trend highlights... More...>>
11/06/20141:09PMBWXenoPort to Present at the Credit Suisse Healthcare Conference
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2014 Credit Suisse Healthcare Conference in Phoenix, Arizona. The live presentation will occur at 8:30 a.m. Pacific Time (9:30 a.m. Mountain Time) on Wednesday, November 12, 2014. A replay of the presentation... More...>>
11/04/20144:06PMBWXenoPort Reports Third Quarter Financial Results
Reports Significant Year-Over-Year HORIZANT Sales Growth XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2014. Revenues for the third quarter were $31.1 million compared to $2.5 million for the same period in 2013. Revenues for the third quarter... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq xnpt150805 02:27